Scientific Research Policy for Health in Portugal: I - European and National Environment

Authors

  • Cátia Sá Guerreiro R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Zulmira Hartz R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Luís Sambo Ministério da Saúde. Governo da República Popular de Angola. Luanda. Angola.
  • Cláudia Conceição R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Gilles Dussault R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Giuliano Russo R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Miguel Viveiros R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Henrique Silveira R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.
  • Pedro Pita Barros Nova School of Business and Economics. Universidade Nova de Lisboa. Lisboa. Portugal
  • Paulo Ferrinho R&D Unit. Instituto de Higiene e Medicina Tropical. Universidade Nova de Lisboa. Lisboa. Portugal.

DOI:

https://doi.org/10.20344/amp.8011

Keywords:

Biomedical Research, Health Services Research, National Health Programs, Portugal, Public Health

Abstract

The global debate on scientific research policy for human health has been led by World Health Organisation with important contributions from other stakeholders such as Council on Health Research for Development, the World Bank and the Global Forum for Health Research. Recently it has been dominated by the thematic agendas of major global financiers. There is a growing interest worldwide in making better use of the evidence resulting from scientific research in health, in the decision-making process regarding health policies, which is fraught with difficulties, as it is the case in Europe. After more than 40 years of democracy and 30 years of European integration, Portugal has bridged the research gap it had previously. However, when compared to global and European research policies, Portugal still has a long way to go regarding investment in research and development.

Downloads

Download data is not yet available.

Downloads

Published

2017-02-27

How to Cite

1.
Sá Guerreiro C, Hartz Z, Sambo L, Conceição C, Dussault G, Russo G, Viveiros M, Silveira H, Pita Barros P, Ferrinho P. Scientific Research Policy for Health in Portugal: I - European and National Environment. Acta Med Port [Internet]. 2017 Feb. 27 [cited 2024 Nov. 22];30(2):141-7. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/8011

Issue

Vol. 30 No. 2 (2017): February

Section

Review Articles

License

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC